Price Chart

Headline
Wire
Time (ET)
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/19/2022 -- Results Q3 2022 -- 0.93 --
10/19/2022 09:00 EST Earnings Call Q3 2022 -- -- --
07/20/2022 09:00 EST Earnings Call Q2 2022 -- -- --
07/20/2022 -- Results Q2 2022 1.43 1.14 25.29%
04/20/2022 -- Results Q1 2022 1.73 1.46 18.09%
04/20/2022 09:00 EST Earnings Call Q1 2022 -- -- --
01/26/2022 -- Results Q4 2021 1.32 1.21 9.48%
01/26/2022 09:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/19/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/20/2022
Beat/Miss Upgrade
Return Since -4.48%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
URL https://www.abbottinvestor.com
Investor Relations URL https://www.abbott.com/investors.html
HQ State/Province Illinois
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Oct. 19, 2022
Last Earnings Release Jul. 20, 2022
Next Ex-Dividend Date Oct. 13, 2022
Last Ex-Dividend Date Jul. 14, 2022

Dividends

Dividend Per Share (TTM) 1.84
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 1.225
Yield to Sector 0.975
Yield to Industry 1.012
Last Dividend Amt. 0.47
Dividend Frequency Quarterly
Last Ex-Dividend Date Jul. 14, 2022
Yield (TTM) 1.82%
Forward Yield 1.82%
Payout Ratio 38.10%
Cash Payout Ratio 38.49%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
1.89%
-12.32%
52.00%
29.04%
22.10%
28.00%
30.54%
-25.66%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.66%
--
--
--
--
--
136.2%
71.93%
59.93%
3.26%
16.11%
72.64%
31.23%
23.43%
38.39%
31.76%
-43.95%
0.01%
30.68%
30.84%
2.43%
35.33%
18.15%
10.22%
-18.42%
12.64%
9.23%
31.23%
6.62%
22.20%
-6.75%
1.88%
-4.88%
As of October 05, 2022.

Profile

Edit
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
URL https://www.abbottinvestor.com
Investor Relations URL https://www.abbott.com/investors.html
HQ State/Province Illinois
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Oct. 19, 2022
Last Earnings Release Jul. 20, 2022
Next Ex-Dividend Date Oct. 13, 2022
Last Ex-Dividend Date Jul. 14, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
IHI 883.23M USD 15.02%
XLV 1.418B USD 3.79%
VHT 610.25M USD 3.28%
CAFFX 1.772B USD 2.70%
CICFX 2.440B USD 2.43%
CMLFX 1.651B USD 2.00%
VIG 1.122B USD 1.53%
VIVAX 1.573B USD 1.09%
VTV 1.573B USD 1.09%
IWD 422.42M USD 0.87%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter ABT Tweets